Global Pharmaceuticals & Biotech Big Green Snowflakes

Betta Pharmaceuticals

Market Cap: CN¥29.5b

Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.

Original BioMedicals

Market Cap: NT$826.1m

A biotechnology company, chemical entities to solve unmet medical needs in Taiwan.

Guangdong Zhongsheng Pharmaceutical

Market Cap: CN¥17.1b

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Genfit

Market Cap: €176.2m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Nuformix

Market Cap: UK£2.5m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

Euroapi

Market Cap: €272.3m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Respiratorius

Market Cap: SEK 39.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Caribou Biosciences

Market Cap: US$171.3m

A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.

Attana

Market Cap: SEK 38.4m

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Atea Pharmaceuticals

Market Cap: US$250.8m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Relmada Therapeutics

Market Cap: US$51.8m

Operates as a clinical-stage biotechnology company in the United States.

Zentalis Pharmaceuticals

Market Cap: US$115.4m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Anika Therapeutics

Market Cap: US$125.9m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Cyclacel Pharmaceuticals

Market Cap: US$14.9m

A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.

Sionna Therapeutics

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Heron Therapeutics

Market Cap: US$199.3m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

AN2 Therapeutics

Market Cap: US$31.7m

A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.

Citius Oncology

Market Cap: US$148.9m

Focuses on the development and commercialization of innovative targeted oncology therapies.

Clearmind Medicine

Market Cap: US$5.3m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Polyrizon

Market Cap: US$11.2m

A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.

Veru

Market Cap: US$50.8m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

Alaunos Therapeutics

Market Cap: US$5.1m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

Entera Bio

Market Cap: US$84.9m

A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.

Revelation Biosciences

Market Cap: US$4.0m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Nuvation Bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Beam Therapeutics

Market Cap: US$2.0b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

TransCode Therapeutics

Market Cap: US$9.3m

A biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

Danaher

Market Cap: US$139.2b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Syndax Pharmaceuticals

Market Cap: US$1.4b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Theravance Biopharma

Market Cap: US$693.0m

A biopharmaceutical company, develops and commercializes of medicines in the United States.

TMS

Market Cap: JP¥6.9b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.

Hinova Pharmaceuticals

Market Cap: CN¥5.5b

A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.

ISU Abxis

Market Cap: ₩215.7b

A biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide.

Aligned Genetics

Market Cap: ₩47.0b

Offers cellular imaging and biomolecular analysis solutions worldwide.